Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts)
暂无分享，去创建一个
W. Pierceall | G. Martinelli | B. Higgins | J. Zhi | S. Middleton | K. Yee | Sung-Soo Yoon | N. Vey | K. Seiter | M. Dickinson | M. Kasner | M. Drummond | K. Kelly | Je-Hwan Lee | S. Assouline | Gong Chen | S. Blotner | G. Nichols | Hua Zhong | Lin-Chi Chen | S. Yoon